AEON Biopharma, Inc. - Common Stock (AEON) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
AEON on NYSE
Shares outstanding
11,898,571
Price per share
$1.09
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
212,117
Total reported value
$233,328
% of total 13F portfolios
0%
Share change
-8,792
Value change
-$1,508
Number of holders
15
Price from insider filings
$1.09
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AEON Biopharma, Inc. - Common Stock (AEON) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Chernett Jorey 9.9% $564,250 1,128,500 Chernett Jorey 27 May 2025
Alta Partners LLC 2.1% -60% $192,400 -$259,078 249,870 -57% Alta Partners LLC 30 Sep 2025
Dauntless Investment Group, LLC 9.7% $44,372 108,224 Dauntless Investment Group, LLC 26 Feb 2025

As of 31 Dec 2025, 15 institutional investors reported holding 212,117 shares of AEON Biopharma, Inc. - Common Stock (AEON). This represents 1.8% of the company’s total 11,898,571 outstanding shares.

Institutional Holders of AEON Biopharma, Inc. - Common Stock (AEON) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 212,117 $233,328 -$1,508 $1.10 15
2025 Q3 1,364,447 $1,103,333 +$78,032 $0.81 21
2025 Q2 1,271,217 $585,730 -$147,232 $0.76 18
2025 Q1 1,526,776 $884,785 +$884,785 $0.58 15